- The Washington Times - Friday, February 4, 2011

As the saying goes, the plural of “anecdote” isn’t “data.” That is, un- less the anecdote supports your theory. Here’s a personal anecdote - a story of how the system works.

Being adopted, I have no family history, so when I suffered through some late-night chest pains, I figured I’d better act on the warning signals. I called my general practitioner and got a same-day consultation, resulting in a next-day referral to a cardiologist and a stress test. Diagnosis: arterial blockage and an immediate referral to New York University Medical Center for an angiogram. Forty-eight hours later, I had two stents and was home - writing this report.

My situation is not unique, but because I am in the business of health care policy, some of the things that happened to me struck me as indicative of some broader themes.



1. Facts vs. fear: After I was admitted into the cardiac unit, got my wrist ID and gave some blood, my first visit was with a nurse practitioner who began her explanation of stents as follows, “You might have read some newspaper articles about how stents are overused and dangerous. That’s crap. They save lives, they’re safe, and it’s a lot more pleasant than open-heart surgery.”

This before she asked me what I did for a living.

2. The evils of pharmaceuticals: After the obligatory (and important) lecture about the need to eat more healthfully and exercise more regularly, one of the residents said to me, “And we’re big believers in pharmaceutical intervention - don’t believe everything you read in the newspaper.”

This before he asked me what I did for a living.

3. Problems with the FDA: When I told the interventional cardiologist that I was a former Food and Drug Administration associate commissioner and was at the agency when the first drug eluting stent was approved, his comment was, “That’s something you should be proud of.”

Advertisement

That, despite all the middle-of-the-night poking and prodding (and my roommate’s bed-rattling basso profundo snoring) made my visit a more meaningful and memorable experience.

4. The cost of innovation: As I walked in my own front door a mere 26 hours after my surgery, ready for action, I remembered my father. His first heart attack (when he was only slightly older than I am today) landed him in the hospital, where his sternum was split open and a bypass performed. It was a dangerous operation followed by a lengthy hospital stay and a prolonged, homebound period of recovery. That was then. He had the best there was at the time - top-notch, 20th-century surgical technique and pharmaceutical therapy. It was very expensive and left him with a scar the size and shape of a Sonoran gopher snake.

More than 20 years later, all I have to remember my surgery by is a small catheter incision and a handful of booklets on heart-healthy nutrition.

Which I plan to read and act on. Tennis anyone?

Peter Pitts is president of the Center for Medicine in the Public Interest and a former FDA associate commissioner.

Advertisement

Copyright © 2025 The Washington Times, LLC. Click here for reprint permission.

Please read our comment policy before commenting.